Insider Transactions Reported by 19 Insiders of Caribou Biosciences, Inc.

Symbol
CRBU on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Berkeley, CA

Insiders trading volume in the past year

Caribou Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other* $9.84M Jul 27, 2021
Rachel E. Haurwitz President and CEO, Director $3.74M +$20.4K +0.55% Mar 14, 2025
Barbara G. Mcclung Chief Legal Officer $951K -$4.81K -0.5% Feb 20, 2025
Steven Kanner Chief Scientific Officer $641K -$4.81K -0.75% Feb 20, 2025
Jason O'Byrne Chief Financial Officer $512K Feb 20, 2024
Ruhi Ahmad Khan Chief Business Officer $443K -$4.81K -1.07% Feb 20, 2025
Syed Ali-aamir Rizvi Chief Medical Officer $352K Feb 21, 2023
Ryan Fischesser VP of Finance and Controller $320K Nov 20, 2024
David Lee Johnson Director $106K Feb 20, 2025
Dara Richardson-Heron Director $106K Feb 20, 2025
Scott Braunstein Director $106K Feb 20, 2025
Natalie Sacks Director $106K Feb 20, 2025
Andrew Guggenhime Director $106K Feb 20, 2025
Nancy Whiting Director $57.8K Feb 20, 2025
Ran Zheng Director $57.8K Feb 20, 2025
Timothy P. Kelly Chief Technology Officer $50.6K Feb 20, 2025
Sriram Ryali Chief Financial Officer $24.7K +$24.7K Jan 29, 2025
Tina M. Albertson Chief Medical Officer $19.7K Feb 20, 2025
Jeffrey Long-McGie Director Jul 22, 2021

Recent Insider Transactions by Companies or Individuals for Caribou Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.